Nano formulation approaches for curcumin delivery-a review

K Gayathri, M Bhaskaran, C Selvam… - Journal of Drug Delivery …, 2023 - Elsevier
Curcumin is a polyphenol molecule derived from Curcuma longa Linn's rhizomes. Curcumin
appears to have been the target of substantial research, with cancer, viral, fungal infections …

Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects

M Ashrafizadeh, A Zarrabi, F Hashemi, ER Moghadam… - Life sciences, 2020 - Elsevier
Dealing with cancer is of importance due to enhanced incidence rate of this life-threatening
disorder. Chemotherapy is an ideal candidate in overcoming and eradication of cancer. To …

Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics

S Patra, B Pradhan, R Nayak, C Behera, L Rout… - Seminars in cancer …, 2021 - Elsevier
The frequent inefficiency of conventional cancer therapies due to drug resistance, non-
targeted drug delivery, chemotherapy-associated toxic side effects turned the focus to …

Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo

C Pi, W Zhao, M Zeng, J Yuan, H Shen, K Li, Z Su… - Drug Delivery, 2022 - Taylor & Francis
The main aim of this study was to improve the therapeutic potential of a paclitaxel (PTX) and
curcumin (CU) combination regimen using solid lipid nanoparticles (SLNs). PTX and CU …

[HTML][HTML] Current understanding of flavonoids in cancer therapy and prevention

M Farhan, A Rizvi, M Aatif, A Ahmad - Metabolites, 2023 - mdpi.com
Cancer is a major cause of death worldwide, with multiple pathophysiological
manifestations. In particular, genetic abnormalities, inflammation, bad eating habits …

Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy

K Xiong, Y Zhang, Q Wen, J Luo, Y Lu, ZX Wu… - International journal of …, 2020 - Elsevier
Multi-drug chemotherapy has been one of the most popular strategies for the treatment of
malignant tumors, and has achieved desirable therapeutic outcomes. The objective of the …

Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article

AM Khalifa, MA Elsheikh, AM Khalifa… - Journal of Controlled …, 2019 - Elsevier
Ovarian carcinoma (OC) is one of the leading causes of death among gynecologic
malignancies all over the world. It is characterized by high mortality rate because of the lack …

[HTML][HTML] Therapeutic role of curcumin and its novel formulations in gynecological cancers

MH Pourhanifeh, M Darvish, J Tabatabaeian… - Journal of Ovarian …, 2020 - Springer
Gynecological cancers are among the leading causes of cancer-associated mortality
worldwide. While the number of cases are rising, current therapeutic approaches are not …

Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy

Y Li, Y Gao, X Zhang, H Guo, H Gao - International journal of pharmaceutics, 2020 - Elsevier
Ovarian cancer is the most common cause of death among gynecological malignancies
globally. Ovarian cancer treatment integrates debulking surgery and systemic therapy …

Nanoparticle delivery systems to combat drug resistance in ovarian cancer

EM Miller, TM Samec, AA Alexander-Bryant - … Nanotechnology, Biology and …, 2021 - Elsevier
Due to the lack of early symptoms and difficulty of accurate diagnosis, ovarian cancer is the
most lethal gynecological cancer faced by women. First-line therapy includes a combination …